Sanofi Chief Executive Paul Hudson said on Monday that the company has not made a final decision yet on how it plans to split ...

B.Riley Financial analyst William Wood has reiterated their bullish stance on IMUX stock, giving a Buy rating on September 16. William Wood ...

PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE DEVELOPMENT OF MASITINIB IN PROGRESSIVE FORMS OF MULTIPLE ...

As usual, a second trial will be needed before UCB and Biogen can file dapirolizumab pegol with regulators. It will be called ...

More and more research suggests that gut microbiome metabolites could hold the key to treating nearly every disease.

Very often the biggest decisions in life occur by chance. I went into gastroenterology when I was still very young, starting ...

Systemic sclerosis is an autoimmune disease that primarily causes inflammation of the skin, as well as internal organs such ...

For people with multiple sclerosis (MS), a higher burden of comorbidity is associated with worse clinical outcomes, according ...

The revisions signal a shift toward looking at MS more as a biologically based disease, noted Xavier Montalban, MD, PhD, of ...

The following is a summary of “Clustering of clinical symptoms using large language models reveals low diagnostic specificity of proposed alternatives to consensus mast cell activation syndrome ...

Knowing Neurons has been built by many people who have moved forward to have successful careers in science and scicomm. Learn more about them here!